4//SEC Filing
Intra-Cellular Therapies, Inc. 4
Accession 0001209191-16-153908
CIK 0001567514operating
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:35 PM ET
Size
7.2 KB
Accession
0001209191-16-153908
Insider Transaction Report
Form 4
ALAFI MOSHE
10% Owner
Transactions
- Purchase
Common Stock
2016-12-07$16.14/sh+20,826$336,038→ 3,695,205 total(indirect: By LLC) - Purchase
Common Stock
2016-12-06$16.33/sh+44,174$721,445→ 3,674,379 total(indirect: By LLC)
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.28 to $16.50 per share, inclusive.
- [F2]Mr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Mr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.91 to $16.37 per share, inclusive.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001567514
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 4:35 PM ET
- Size
- 7.2 KB